Your browser is no longer supported. Please, upgrade your browser.
ABT Abbott Laboratories daily Stock Chart
Abbott Laboratories
IndexS&P 500 P/E32.38 EPS (ttm)1.30 Insider Own0.30% Shs Outstand1.47B Perf Week0.76%
Market Cap62.21B Forward P/E17.15 EPS next Y2.46 Insider Trans16.65% Shs Float1.47B Perf Month-2.27%
Income1.95B PEG3.46 EPS next Q0.58 Inst Own73.90% Short Float4.41% Perf Quarter11.98%
Sales20.56B P/S3.03 EPS this Y53.50% Inst Trans4.30% Short Ratio6.49 Perf Half Y4.47%
Book/sh14.02 P/B3.01 EPS next Y11.87% ROA5.60% Target Price7.51 Perf Year3.07%
Cash/sh3.01 P/C14.02 EPS next 5Y9.36% ROE10.90% 52W Range35.56 - 45.79 Perf YTD-4.30%
Dividend1.04 P/FCF307.97 EPS past 5Y-10.30% ROI7.70% 52W High-7.86% Beta1.21
Dividend %2.47% Quick Ratio1.20 Sales past 5Y-10.30% Gross Margin56.90% 52W Low18.64% ATR0.70
Employees74000 Current Ratio1.50 Sales Q/Q3.20% Oper. Margin14.00% RSI (14)49.32 Volatility1.33% 1.74%
OptionableYes Debt/Eq0.41 EPS Q/Q-22.60% Profit Margin11.10% Rel Volume0.69 Prev Close42.22
ShortableYes LT Debt/Eq0.29 EarningsOct 19 BMO Payout66.50% Avg Volume9.95M Price42.19
Recom2.00 SMA200.63% SMA50-2.36% SMA2003.47% Volume6,912,285 Change-0.07%
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Sep-23-16 05:07PM  The Rationale behind Johnson & Johnsons Acquisition of Abbott Medical Optics
08:00AM  Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
Sep-21-16 02:00PM  Disease-related malnutrition costs U.S. $15.5 bln annually - study
02:00PM  Malnutrition Adds $15.5 Billion Annually to Direct U.S. Medical Costs PR Newswire
10:29AM  Bristol-Myers Opdivo's Regulatory Application Validated in EU
09:30AM  The Zacks Analyst Blog Highlights: Abbott Labs, Comcast, Goldman Sachs, Microsoft and Philip Morris
09:00AM  Abbott Hosts Conference Call for Third-Quarter Earnings PR Newswire
Sep-20-16 11:38AM  Top Research Reports for Goldman Sachs, Comcast & Abbott Labs
11:18AM  Johnson & Johnson's Smart (Yet Surprising) Acquisition at Motley Fool
11:02AM  [$$] Abbott's Deal With JNJ Is Good Strategy at
09:00AM  Fueling Performance with Fat: EAS® Launches First Ketogenic Meal Replacement For Athletes PR Newswire
Sep-19-16 05:35PM  Abbott Laboratories -- Moody's expectations for Abbott's ratings unchanged following news of medical optics sale at Moody's
05:11PM  Abbott Method for Assessing Red Blood Cells Receives Patent
01:15PM  Abbott's Eye Deal Isn't About Alere at Bloomberg
11:41AM  US stocks rise as banks climb before Federal Reserve meeting
10:16AM  Credit Suisse Can Clearly See Why Johnson & Johnson Acquired Abbott's Optics Division
09:20AM  Blog Coverage Johnson and Johnson Acquires Abbott Laboratories Optic Unit
08:16AM  J&J (JNJ) to Buy Abbott's Vision Care Unit for $4.3 Billion
Sep-18-16 12:08PM  Tesla, TerraForm, and Johnson & Johnson Among the Biggest Weekend Newsmakers at Insider Monkey
Sep-17-16 11:47AM  AP Top Extended Financial Headlines at 11:47 a.m. EDT
Sep-16-16 11:43PM  [$$] J&J to Buy Abbotts Eye-Surgery Equipment Unit for $4.325 billion at The Wall Street Journal
07:13PM  The 3 Best Long-Term Dividend Stocks to Buy Now at Motley Fool
05:57PM  [$$] J&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion at The Wall Street Journal
05:48PM  Abbott to sell its eye care business to J&J for about $4.33 billion
05:43PM  Abbott to sell its eye care business to J&J for about $4.33 bln
05:05PM  Johnson & Johnson Sees Growth in Ophthalmology, Acquires Abbott Medical Optics
05:03PM  ABBOTT LABORATORIES Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement
04:13PM  Johnson & Johnson to buy Abbott's vision unit for $4.33B
04:10PM  Abbott is selling its vision unit to Johnson & Johnson at
03:27PM  Abbott (ABT) Stock Higher as Johnson & Johnson to Buy Medical Optics Unit
03:18PM  Johnson & Johnson (JNJ) Stock Lower, Buys Abbott Laboratories' Medical Optics Unit for $4.3 Billion
03:16PM  Johnson & Johnson to buy Abbott Medical Optics for $4.33 billion in cash at CNBC
03:13PM  Johnson & Johnson to buy Abbott Labs medical optics subsidiary for $4.3bln at MarketWatch
03:08PM  J&J buys Abbott Labs unit for $4.3B in cash
03:06PM  J&J to Buy Abbott Eye Surgery Unit for $4.33 Billion at Bloomberg
03:00PM  Abbott to Sell Abbott Medical Optics to Johnson & Johnson for $4.325 Billion PR Newswire
01:23PM  Abbott in talks to sell its eye-surgery business to J&J - WSJ
Sep-15-16 09:00AM  Abbott Declares 371st Consecutive Quarterly Dividend PR Newswire
Sep-14-16 08:17AM  AbbVie's Battle Royale
Sep-13-16 08:25AM  Deutsche Bank Says Buy Dividend-Paying Large Caps With Low Price to Earnings at 24/7 Wall St.
Sep-12-16 09:30AM  Can Abbott Labs Find a Cure for Its Ailing Shares?
Sep-11-16 05:09PM  Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression
07:39AM  3 Great Dividend Stocks in the Bargain Bin for Retirees at Motley Fool
Sep-09-16 06:04PM  New Long-Term Data Reaffirm the Benefits of Medtronics Micra TPS
Sep-08-16 03:13PM  [$$] Abbott Labs Sustaining Growth at
01:54PM  Will Abbott Laboratories (ABT) Stock Be Helped by Mediation in Alere Merger?
01:10PM  Abbott Named Industry Leader for Responsible and Sustainable Business for Four Consecutive Years on the Dow Jones Sustainability Index (DJSI) PR Newswire
12:15PM  Abbott, Alere agree to mediate merger dispute Reuters
Sep-07-16 02:30PM  Reaction to St. Jude Cybersecurity Threat May Be Overdone
01:28PM  Zoetis Remains Attractive Alternative Healthcare Investment
08:50AM  Abbott's Alere pushback could color future dealmaking efforts
07:42AM  Abbott's Alere Pushback Could Color Future Dealmaking Efforts
Sep-06-16 04:49PM  Danaher Buying Cepheid To Expand Diagnostics Business
10:26AM  Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids
09:30AM  Here's what you missed on your summer vacation in life science news at
08:20AM  4 Large Cap Dividend Stocks to Buy Now and Never Sell at 24/7 Wall St.
Sep-02-16 03:08PM  AbbVie: Not Your Father's Biotech Company? at
11:59AM  Alere Gets on Courts Fast Track in Suit Over Abbott Buyout
11:08AM  Delaware Judge expedites Alere lawsuit against Abbott
11:07AM  Abbott Laboratories Value Analysis (NYSE:ABT) : September 2, 2016
Sep-01-16 04:42PM  Alere Asks for September Trial in Case Against Abbott
01:17PM  [$$] Abbott Labs/Alere: before and after at Financial Times
08:11AM  Abbott Laboratories breached its 50 day moving average in a Bearish Manner : ABT-US : September 1, 2016
Aug-31-16 04:04PM  Analyzing C.R. Bards Strong Product Pipeline
03:55PM  Alere lawsuit accuses Abbott of 'buyer's remorse' in proposed merger Reuters
03:25PM  Abbott Should Have Heeded Its Inner Voice at Bloomberg
12:09PM  Alere (ALR) Stock Lower, Says Abbott Has 'Buyer's Remorse' Over Deal
11:11AM  Alere Says Abbott Suffering From Buyers Remorse Over Deal
11:11AM  Abbotts Deal for Alere Turns Nasty as Firms Brawl in Court at Bloomberg
11:04AM  Recent Developments at Johnson & Johnson
10:04AM  How Much Has Medtronic Returned to Shareholders in 1Q17?
09:49AM  Alere Says Abbott Suffering From Buyers Remorse Over Deal at Bloomberg
08:05AM  A Look at Johnson & Johnsons Valuation Compared to Peers
Aug-30-16 02:04PM  How Johnson & Johnsons Partnerships Enhance Customer Value
02:04PM  Analyzing Johnson & Johnsons Business Segments
11:30AM  Alere sues Abbott to complete $5.8B merger at
09:19AM  Post Earnings Coverage as Medtronic Earnings Surge 13 Percent on Lower Tax Bill
Aug-29-16 04:07PM  Medtronic Registers In-Line Earnings, Missed Revenue Estimates
02:42PM  Abbott's Deal Headaches Go Beyond Bad Luck at Bloomberg
01:10PM  An Outside View on St. Jude Device Cyberattack Woes at 24/7 Wall St.
10:10AM  Stock Market News for August 29, 2016
10:02AM  Large trade bets on rally in Abbott Labs
08:38AM  Abbott Labs Sued by Alere over Pending $5.8B Acquisition
Aug-27-16 06:36PM  Here Are All The Big Biotech Mergers In 2016
Aug-26-16 06:38PM  Whiplashed investors stay skittish about St. Jude Reuters
04:21PM  Muddy Waters' Carson Block says St. Jude Medical shares could fall to $55 at CNBC
04:11PM  Abbott's Acquisitions in Question as Issues Arise About Alere, St. Jude
03:33PM  St. Jude Denies Short Sellers Claims; Abbott Remains Committed at Bloomberg
02:04PM  [$$] Alere Sues Abbott to Force Merger at The Wall Street Journal
01:51PM  Alere sues Abbott over $5.8 bln takeover Reuters
12:55PM  Alere shares fall after it sued Abbott over $5.8 billion deal at CNBC
12:52PM  Abbott (ABT) Stock Lower, Alere Sues to Force $5.8 Billion Deal
11:28AM  Alere drags Abbott to court over $5.8 bln deal Reuters
11:14AM  Alere Sues Abbott to Force Completion of $5.8 Billion Deal at Bloomberg
11:14AM  Alere Files Suit Against Abbott on $5.8 Billion Takeover Deal
10:05AM  Whats Thermo Fisher Scientifics Latest Valuation?
Aug-25-16 04:43PM  St. Jude Medical drops after Muddy Water findings of 'negligent product design' at CNBC
01:25PM  Why Abbott Laboratories (ABT) Stock Is Up Today
12:52PM  Will MedSec's St.Jude Claims Impact Abbott Deal?
11:02AM  Carson Block Takes on St. Jude Medical Claiming Hack Risk at Bloomberg
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company's Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company has strategic alliance with Fonterra. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Option Exercise20.753,40070,54591,857Jun 30 05:58 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Sale37.143,400126,27688,457Jun 30 05:58 PM
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM
Ford Robert BExecutive Vice PresidentFeb 29Sale39.281,70667,02060,789Mar 02 07:32 PM
NATH DEEPAK S.Senior Vice PresidentFeb 29Sale39.2779331,14247,571Mar 02 07:30 PM
Fussell Stephen RExecutive Vice PresidentFeb 29Sale39.261,40255,044154,967Mar 02 07:28 PM
Contreras JaimeSenior Vice PresidentFeb 29Sale38.9410,617413,40947,667Mar 02 07:28 PM
Blaser Brian JExecutive Vice PresidentFeb 29Sale39.291,54360,626129,482Mar 02 07:12 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 29Sale39.291,54360,61888,457Mar 02 07:11 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 29Sale39.283,086121,221354,517Mar 02 07:10 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentFeb 29Sale39.2688134,58961,792Mar 02 07:02 PM
YOOR BRIAN BSenior Vice President and CFOFeb 29Sale39.1286533,84351,385Mar 02 07:01 PM
Mason Heather LExecutive Vice PresidentFeb 29Sale39.273,032119,05565,102Mar 02 06:49 PM
Funck Robert EVice President, ControllerFeb 29Sale39.301,33352,39385,019Mar 02 06:07 PM
Warmuth Michael JExecutive Vice PresidentFeb 29Sale38.849,399365,09355,011Mar 02 05:14 PM
Pavee Jean-YvesSenior Vice PresidentFeb 29Sale39.241,66565,32636,149Mar 02 05:09 PM
NATH DEEPAK S.Senior Vice PresidentFeb 22Sale39.0931912,47150,404Feb 23 05:44 PM
Watkin JaredSenior Vice PresidentFeb 22Sale39.0955421,65848,535Feb 23 05:38 PM
NATH DEEPAK S.Senior Vice PresidentFeb 16Sale37.131716,34934,941Feb 17 05:57 PM
WHITE MILES DChairman and CEODec 16Option Exercise21.22438,0009,294,0971,832,153Dec 18 05:01 PM
WHITE MILES DChairman and CEODec 16Sale46.00438,00020,149,9581,394,153Dec 18 05:01 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 28Sale39.6581532,31239,974Sep 29 05:36 PM